ferumoxtran-10: Clinical Trials

2 trials of ferumoxtran-10, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow ferumoxtran-10: new trials by email Literature Review of ferumoxtran-10 trials Research Report on ferumoxtran-10

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose
Gadoterate (Dotarem/Clariscan), Gadobutrol (Gadavist/Gadovist, BAY86-4875) - Magnetic Resonance Imaging
Phase 4CompletedBayer1572018-11-142021-06-14
Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
Superparamagnetic Iron Oxide Magnetic Resonance Imaging - Pancreatic Cancer
Phase 4CompletedMassachusetts General Hospital352008-07-012017-07-25

Conditions studied

Pancreatic Neoplasms (1)

Sponsors

Bayer (1)  ·  Massachusetts General Hospital (1)

Countries

United States (2)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  South Korea (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Ralph Weissleder, MD, PhD (1)

Results publications

PMID 34133205

NIH funding

2018 (1)